Tag: voxelotor

January 30, 2019

GBT Announces Publication of Data from Phase 1/2 Study of Voxelotor in Patients with Sickle Cell Disease

Global Blood Therapeutics (NASDAQ:GBT) today announced that data from its Phase 1/2 study of voxelotor in patients with sickle cell...
June 27, 2018

GBT Announces Positive Top-line Data from Part A of the Phase 3 HOPE Study of Voxelotor in Sickle Cell Disease

Global Blood Therapeutics (NASDAQ:GBT) announced the completion of a planned review of Part A of the Phase 3 HOPE (Hemoglobin Oxygen...